Royalty Pharma plc (RPRX)
NGS · Common · CUSIP G7709Q104
Last Price•••.••
Current Yield•.••%
Yield to Call•.••%
Yield to Worst•.••%
Free registration unlocks the quote, yield calculations, price chart and full fundamentals for RPRX and every other security on QuantumOnline.
🔒
Price chart and 15 days of daily prices
Candlestick chart with moving averages, Bollinger bands and MACD. Register free to view.

Security Profile

Security Type
Common Stock
CUSIP
G7709Q104
IPO
6/16/2020 · $28.00/share
Business: Royalty Pharma plc is a leading funder of innovation across the biopharmaceutical industry, collaborating with innovators from academic institutions, research hospitals and not-for-profits through small and mid-cap biotechnology companies to leading global pharmaceutical companies. Royalty Pharma has assembled a portfolio of royalties which entitles it to payments based directly on the top-line sales of many of the industry’s leading therapies.

Company Contact

CEO
Pablo Legorreta
CFO
Terrance Coyne
Headquarters
110 East 59th Street, New York, New York 10022
Phone
212-883-0200
Investor Relations
212-883-0200 · ir@royaltypharma.com
SEC EDGAR Filings
View filings »